Hosted on MSN6d
Why Treace Medical Concepts (TMCI) Is Rallying TodayWhy BTIG Upgraded the Shares Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot ...
BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...
Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of ...
JPMorgan assumed coverage of Treace Medical (TMCI) with a Neutral rating and $8 price target While believers in the company’s Lapiplasty value proposition, the firm thinks Treace has more work ...
Jan. 13, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts ... of bunions and related midfoot deformities through its flagship Lapiplasty ® and Adductoplasty ® Procedures, today announced ...
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback